CRBU — Caribou Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $167.31m
- $20.05m
- $9.99m
- 21
- 22
- 55
- 22
Annual cashflow statement for Caribou Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.3 | -66.9 | -99.4 | -102 | -149 |
| Depreciation | |||||
| Non-Cash Items | 0.016 | 4.35 | 11 | 12.6 | 12.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.177 | 29.1 | -4.2 | -7.32 | -5.11 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -33.2 | -32.5 | -91 | -93.3 | -138 |
| Capital Expenditures | -0.317 | -2.12 | -6.45 | -11.6 | -4.88 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 6.68 | -174 | -86.8 | -56.6 | 91.5 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.36 | -176 | -93.2 | -68.2 | 86.6 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.74 | 433 | 2.13 | 154 | 16.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -25.1 | 225 | -182 | -7.18 | -34.9 |